Question 1

- question: "What are the most common side effects of low-dose ketamine?

Accepted Answer

The most frequently reported side effects of sub-anesthetic ketamine include nausea (occurring in approximately 20 to 30 percent of patients), dizziness, dissociation, elevated blood pressure, and drowsiness. During intravenous infusions, patients may experience blurred vision, headache, or a feeling of unreality. These effects are dose-dependent and typically resolve within one to two hours after treatment ends. Nausea can often be managed with ondansetron (Zofran) administered before or during the session -- see our detailed guide on [managing nausea during ketamine therapy](/safety/managing-nausea/). Transient increases in blood pressure and heart rate are common and are monitored throughout treatment. Most side effects diminish with subsequent sessions as patients become more familiar with the experience.

Question 2

Are there serious risks associated with ketamine therapy?

Accepted Answer

Serious adverse events are uncommon at the low doses used in psychiatric treatment but can occur. The primary concerns include significant blood pressure elevation in patients with cardiovascular disease, severe dissociative reactions, and urinary tract complications with prolonged high-dose use. Rare but documented risks include laryngospasm (extremely rare at sub-anesthetic doses), emergence reactions causing agitation or confusion, and transient worsening of psychotic symptoms in vulnerable individuals. Cardiovascular monitoring during sessions helps detect and manage blood pressure spikes. Proper patient screening that excludes individuals with uncontrolled hypertension, active psychosis, or unstable cardiac conditions significantly reduces the risk of serious complications.

Question 3

Can I drive after a ketamine session?

Accepted Answer

No. You must not drive for the remainder of the day following a ketamine treatment session. Ketamine impairs motor coordination, reaction time, and judgment even after the subjective effects have subsided. For intravenous infusions and intranasal esketamine, clinics require you to arrange a designated driver before treatment begins. Most providers recommend waiting at least 12 to 24 hours before driving or operating heavy machinery. For a full overview, see [driving after ketamine treatment](/safety/can-you-drive-after-ketamine/). For at-home sublingual or oral ketamine, the same restrictions apply for the duration of the treatment day. Some patients may feel fully recovered within a few hours, but cognitive and motor impairments can persist subtly longer than perceived.

Question 4

Is ketamine addictive?

Accepted Answer

Ketamine does have abuse potential, and it is classified as a Schedule III controlled substance in the United States. However, the risk of addiction at the low doses and controlled frequency used in clinical psychiatric treatment is considered low. Studies published in the Journal of Clinical Psychiatry have not found significant rates of dependence or misuse among patients receiving supervised ketamine therapy for depression. Read more about [ketamine's addiction potential](/safety/is-ketamine-addictive/). The clinical context matters considerably. Recreational ketamine abuse involves much higher doses, more frequent use, and a different psychological context than medical treatment. Patients with a history of substance use disorders require careful evaluation, and many providers implement additional safeguards such as drug screening and limited take-home prescriptions.

Question 5

What are the long-term safety concerns with ketamine therapy?

Accepted Answer

Long-term safety data for low-dose psychiatric ketamine is still accumulating, as widespread clinical use is relatively recent. The primary long-term concerns include potential urinary tract damage (interstitial cystitis), cognitive effects, and hepatotoxicity. Urological complications, well-documented in chronic recreational users consuming high daily doses, have not been commonly reported at therapeutic doses, though some clinicians monitor urinary symptoms. Cognitive assessments in clinical studies lasting up to one year have generally not shown persistent deficits. Liver function monitoring is recommended for patients on long-term treatment. The American Psychiatric Association recommends ongoing research into the long-term safety profile and suggests periodic reassessment of the risk-benefit ratio for each patient.

Question 6

Will ketamine interact with my other medications?

Accepted Answer

Ketamine has several clinically relevant drug interactions. Benzodiazepines such as lorazepam and clonazepam may reduce ketamine's antidepressant efficacy, and some providers recommend tapering or holding benzodiazepines before treatment when safe to do so. Lamotrigine has also been shown in some studies to attenuate ketamine's effects. Monoamine oxidase inhibitors (MAOIs) can potentially increase the risk of hypertensive crisis when combined with ketamine. Most SSRIs and SNRIs can be safely continued during ketamine therapy. Opioid medications may interact through shared receptor pathways. Always provide your ketamine provider with a complete and current medication list, including supplements and over-the-counter products.

Question 7

Can ketamine cause bladder problems?

Accepted Answer

Bladder toxicity, specifically ketamine-induced cystitis, is a well-documented complication of chronic high-dose recreational ketamine use. Symptoms include urinary frequency, urgency, pain during urination, and in severe cases, a contracted bladder requiring surgical intervention. However, this condition is associated with daily recreational use at doses far exceeding those used in clinical psychiatric treatment. At therapeutic doses administered intermittently, such as biweekly or monthly maintenance infusions, bladder complications have been rarely reported in the medical literature. Nonetheless, providers should ask about urinary symptoms at follow-up visits, and patients should report any changes in urinary function promptly. Long-term patients may benefit from periodic urinalysis.

Question 8

Is ketamine safe for older adults?

Accepted Answer

Low-dose ketamine can be used in older adults, but additional caution is warranted. Age-related cardiovascular changes make blood pressure monitoring especially important, as ketamine's sympathomimetic effects can be more pronounced in elderly patients. Reduced hepatic and renal function in older adults may slow ketamine metabolism, potentially leading to prolonged effects or higher plasma levels at standard doses. Some providers use lower starting doses for patients over 65. Cognitive side effects such as confusion or disorientation may be more prominent in older adults. Studies published in the American Journal of Geriatric Psychiatry have shown that ketamine can be effective and reasonably safe in geriatric patients with treatment-resistant depression when proper monitoring and dose adjustments are implemented.

Safety and Side Effects

Frequently Asked Questions

Related Reading

Low-Dose Ketamine and Cannabis: What Patients Should Know

Ketamine for Depression

Dosing and Administration